[
  {
    "ts": null,
    "headline": "Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=ce931c89be5a5865f0fac4497ab471cbd5834bbf9742a1406c7d0a289adc6e53",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756832880,
      "headline": "Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors",
      "id": 136630735,
      "image": "",
      "related": "DGX",
      "source": "MarketWatch",
      "summary": "Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=ce931c89be5a5865f0fac4497ab471cbd5834bbf9742a1406c7d0a289adc6e53"
    }
  },
  {
    "ts": null,
    "headline": "Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index",
    "summary": "The percentage of employees in the general U.S. workforce testing positive for fentanyl in random drug tests far exceeded those in pre-employment testing, according to the 2025 Quest Diagnostics Drug Testing Index™ from Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services.",
    "url": "https://finnhub.io/api/news?id=7608f78341870e538018d4ea87c4d4dad57d63bd80ddefe4a4cfaf86eb9adcf0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756812420,
      "headline": "Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index",
      "id": 136604613,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "The percentage of employees in the general U.S. workforce testing positive for fentanyl in random drug tests far exceeded those in pre-employment testing, according to the 2025 Quest Diagnostics Drug Testing Index™ from Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services.",
      "url": "https://finnhub.io/api/news?id=7608f78341870e538018d4ea87c4d4dad57d63bd80ddefe4a4cfaf86eb9adcf0"
    }
  },
  {
    "ts": null,
    "headline": "How Investors May Respond To Quest Diagnostics (DGX) Expanding Michigan Lab Services Through Corewell Joint Venture",
    "summary": "Corewell Health and Quest Diagnostics recently announced a definitive agreement to form a joint venture, Diagnostic Lab of Michigan, which will expand innovative and affordable laboratory services across Michigan using advanced technologies and Quest's management expertise. This collaboration not only increases Quest's regional presence but also demonstrates the growing importance of integrated partnerships in delivering high-quality, technology-driven healthcare services. We'll examine how...",
    "url": "https://finnhub.io/api/news?id=3e9faae5573d3a2acfdae12c423f06f082acb2d1cb5f0fcb0dbd43bea858c2b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756811222,
      "headline": "How Investors May Respond To Quest Diagnostics (DGX) Expanding Michigan Lab Services Through Corewell Joint Venture",
      "id": 136604614,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Corewell Health and Quest Diagnostics recently announced a definitive agreement to form a joint venture, Diagnostic Lab of Michigan, which will expand innovative and affordable laboratory services across Michigan using advanced technologies and Quest's management expertise. This collaboration not only increases Quest's regional presence but also demonstrates the growing importance of integrated partnerships in delivering high-quality, technology-driven healthcare services. We'll examine how...",
      "url": "https://finnhub.io/api/news?id=3e9faae5573d3a2acfdae12c423f06f082acb2d1cb5f0fcb0dbd43bea858c2b0"
    }
  },
  {
    "ts": null,
    "headline": "More Fentanyl Shows Up in Random Workplace Tests",
    "summary": "More Americans are testing positive for fentanyl use, highlighting a persistent challenge for employers.",
    "url": "https://finnhub.io/api/news?id=ca8d1c351e79568850d448923018596b27d14b9fd8ee040e807ce983a17878b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756807200,
      "headline": "More Fentanyl Shows Up in Random Workplace Tests",
      "id": 136604615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "More Americans are testing positive for fentanyl use, highlighting a persistent challenge for employers.",
      "url": "https://finnhub.io/api/news?id=ca8d1c351e79568850d448923018596b27d14b9fd8ee040e807ce983a17878b1"
    }
  }
]